MyFinsight
Home
Blog
About
Contact
Download
Download image
Product
$271,345K
License Collaboration
And Royalty Revenue
$11,710K
Total revenue
$283,055K
(20.38%↑ Y/Y)
Income (loss) from
operations
$104,914K
(2338.40%↑ Y/Y)
Interest income
$13,573K
(-20.02%↓ Y/Y)
Total operating
expenses
$178,141K
(-25.72%↓ Y/Y)
Income tax (benefit)
expense
-$173,045K
(-10303.13%↓ Y/Y)
Net income (loss)
before income taxes
$114,157K
(1432.72%↑ Y/Y)
Interest expense
$4,330K
(-10.44%↓ Y/Y)
Selling, general and
administrative
$101,794K
(-40.83%↓ Y/Y)
Cost of revenue
$32,665K
(15.64%↑ Y/Y)
Research and development
$32,505K
(56.39%↑ Y/Y)
Other expense
(income), net
-$9,530K
(-319.23%↓ Y/Y)
Restructuring
$1,647K
(-92.87%↓ Y/Y)
Net income (loss)
$287,202K
(4893.08%↑ Y/Y)
Unrealized gain on
available-for-sale securities
$48K
(-42.17%↓ Y/Y)
Comprehensive income (loss)
$287,250K
(4822.88%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)